How many institutions held FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share in Q2 2020?

22 institutional investors reported FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share for Q2 2020. Use the holders table for investor-level position and value details.

Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX)

Q: What does CUSIP 34962G109 represent in this 13F holders report?

CUSIP 34962G109 is the security identifier for FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 34962G109

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 20,563,488
Total 13F shares: 2,883,976
Share change: +2,883,976
Total reported value: $42,049,000
Price per share: $14.58
Number of holders: 22
Value change: +$42,049,000
Number of buys: 22

Quarterly Holders Quick Answers

What is CUSIP 34962G109?
CUSIP 34962G109 identifies FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 34962G109:

Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022

Top shareholders of FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
CWM, LLC	13F	Company	0%	66	$2,000	—	31 Mar 2020	13F

Institutional Holders of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) as of Q2 2020

As of 30 Jun 2020, Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,883,976 shares. The largest 10 holders included BVF INC/IL, ORBIMED ADVISORS LLC, FRED ALGER MANAGEMENT, LLC, VANGUARD GROUP INC, BlackRock Inc., MYDA Advisors LLC, GEODE CAPITAL MANAGEMENT, LLC, CIBC Private Wealth Group, LLC, LPL Financial LLC, and TOCQUEVILLE ASSET MANAGEMENT L.P.. This page lists 22 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

Q2 2020 holders

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.